Endometroid Adenocarcinoma: A Possibility after Hysterectomy

Nikhil Purandare, Gillian Ryan, Fathl Ramli, Kara Purcell, Andrew Curtain, Morgan McCourt
In: Journal of South Asian Federation of Obstetrics and Gynaecology · 2010 · vol. 2(3) , pp. 230–232 · doi:10.5005/jp-journals-10006-1108 · W2114099602
Case report OA: bronze CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-12 ⓘ

This case report describes a 57-year-old woman with a history of endometriosis who developed an endometrioid adenocarcinoma after hysterectomy and bilateral salpingo-oophorectomy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Malignant transformation is a rare sequelae of endometriosis. We report a case of Mrs. GR who was a 57-year-old, nulliparous woman. She presented with passing fecal matter vaginally and a left pelvic mass increasing in size and discomfort. She had a history of subtotal hysterectomy and bilateral salpingo-oophrectomy for endometriosis and was incidentally found to have a benign Sertoli-Leydig cell tumor in a single ovary. She subsequently had a CT scan confirming the presence of a mass greater than 9 cm in size. The biopsy suggested endometrioid adenocarcinoma. Our case shows possibility of malignant transformation of endometriosis after hysterectomy and bilateral salpingo-oophrectomy in a patient with a prior history of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (17)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK